Drug Discovery News
-
Otsuka collaborates with X-Chem for new drug compounds
Drug Discovery | News | 0 Comment | 26 Dec, 2017
US based X-Chem, Inc. and Otsuka Pharmaceutical Co., Ltd., a subsidiary of Otsuka Holdings Co., Ltd. headquartered in Tokyo, Japan, have signed a collaborative research agreement to advance...Read more
-
Adaptive Phase II Study of BAN2401 in Early Alzheimer’s Disease Continues toward 18-Month Endpoint
Drug Discovery | News | 0 Comment | 22 Dec, 2017
Eisai Co., Ltd. and Biogen Inc. has announced that an Independent Data Monitoring Committee has determined that BAN2401, an anti-amyloid beta protofibril antibody, did not meet the criteria...Read more
-
Confo Therapeutics enters into collaboration with Roche
Drug Discovery | News | 0 Comment | 20 Dec, 2017
Drug Discovery company, Confo Therapeutics has announced that it has entered into a research collaboration and license agreement with Roche for the discovery, development and commercialisat...Read more
-
Researchers show patients' own immune cells can fight deadly cancers
Drug Discovery | News | 0 Comment | 15 Dec, 2017
Singapore - Scientists have taken a significant step forward in efforts to harness our own white blood cells to fight deadly cancers. A pilot study, funded by Montefiore Einstein Cente...Read more
-
Bioelectronic medicine to treat lupus
Drug Discovery | News | 0 Comment | 15 Dec, 2017
Singapore - Researchers at Northwell Health's Feinstein Institute for Medical Research are conducting a clinical trial to evaluate the efficacy of bioelectronic medicine to treat ...Read more
-
Sirenas receives $1.68 M research grant to accelerate ATLANTIS
Drug Discovery | News | 0 Comment | 13 Dec, 2017
Singapore – Sirenas, a biotechnology company harnessing computational approaches to discover therapeutics derived from nature's chemistry, announced that it has received a new grant f...Read more
-
Kenalog-40 Injection approved and available through Amneal Biosciences
Drug Discovery | News | 0 Comment | 13 Dec, 2017
Singapore - Amneal Biosciences (a US based pharmaceutical manufacturing company) received approval for its Triamcinolone Acetonide Injectable Suspension, USP in 40 mg/mL dosage strengt...Read more
-
Drug Discovery | News | 0 Comment | 13 Dec, 2017
Singapore - The U.S. Food and Drug Administration (FDA) has approved Sanofi's Admelog, the first follow-on insulin lispro to help people living with diabetes manage blood sugar levels at me...Read more
-
JW Pharma releases cancer treatment trial results
Drug Discovery | News | 0 Comment | 12 Dec, 2017
South Korea based JW Pharmaceuticals recently presented phase 1a/1b clinical trial results for CWP291, a target anticancer treatment that uses Wnt signaling pathway, at the American Society...Read more
-
Sanofi ends development of Clostridium difficile vaccine
Drug Discovery | News | 0 Comment | 05 Dec, 2017
The pharma giant Sanofi has recently announced that it will terminate its late-stage program for a Clostridium difficile vaccine. According to the company statement, “Sanofi Pasteur,...Read more
-
Pfizer inks drug development and commercialization deal with Basilea Pharma
Drug Discovery | News | 0 Comment | 01 Dec, 2017
Global pharmaceutical giant Pfizer has inked a strategic deal with Basilea Pharmaceutical, an international biopharmaceutical company specializing in the research and development of anti-in...Read more
-
Achievement of Biotech Company: Treat Burns with Pineapples
Drug Discovery | News | 0 Comment | 27 Nov, 2017
Nasdaq-listed, Israel-headquartered biotechnology company MediWound Ltd. is attempting to revolutionize the way doctors treat second and third-degree burns. To do so, it is using a patente...Read more
-
Khondrion presents Phase II KHENERGY trial data
Drug Discovery | News | 0 Comment | 23 Nov, 2017
Clinical stage pharma company, Khondrion focusing on small molecule therapeutics for mitochondrial diseases has announced results from its KHENERGY study. This study is Phase II explorator...Read more
-
Novel in vitro model investigates drug candidates for cancer metastasis
Drug Discovery | News | 0 Comment | 22 Nov, 2017
Singapore - ATCC, an established and trusted source of biological materials in the R&D community, announced the release of an innovative, in vitromodel system for a key mechanism o...Read more
-
Gamida Cell appoints Julian Adams as chairman and CEO
Drug Discovery | News | 0 Comment | 21 Nov, 2017
Cellular and immune therapeutics company, Gamida Cell has announced the appointment of Julian Adams as chairman and chief executive officer. Dr. Adams has more than 30 years of drug discov...Read more
-
NDA submission for Starpharma’s VivaGel BV
Drug Discovery | News | 0 Comment | 21 Nov, 2017
Singapore - Australian biotech company Starpharma submitted its New Drug Application (NDA) with the US FDA through a rolling submission process for its VivaGel BV product which targets trea...Read more
-
Mitsubhishi Tanabe Pharma's ALS drug treats more than 1000 people in three months
Drug Discovery | News | 2 Comment | 17 Nov, 2017
Japan’s Mitsubishi Tanabe Pharma America, Inc. today announced that more than 1,000 people with amyotrophic lateral sclerosis (ALS) have been treated with RADICAVA® (edaravon...Read more
-
Drug Discovery | News | 0 Comment | 15 Nov, 2017
Seres Therapeutics, The University of Texas MD Anderson Cancer Center (MD Anderson), and the Parker Institute for Cancer Immunotherapy (Parker Institute) has announced a coll...Read more
